Abstract
Gastric cancer is one of the most common types of cancers worldwide, with the intestinal pathological variant common among elderly men, and the diffuse type common in woman and individuals under the age of 50. FOLFOX (oxaliplatin, fluorouracil [5-FU], and leucovorin) is an approved chemotherapy regimen for the treatment of gastric cancer. Despite advances in systemic therapies, long-term survival in gastric cancer remains poor. TTFields are alternating electrical fields that display an antimitotic effect on cancer cells.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Annals of oncology : official journal of the European Society for Medical Oncology
Paper Title
Journal
Date
